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Duplex ultrasound of the superficial femoral
artery is a better screening tool than ankle-brachial
index to identify at risk patients with lower
extremity atherosclerosis
D. Preston Flanigan, MD,a Jeffrey L. Ballard, MD,a,b Doreen Robinson, RN, CRC,a
Mark Galliano, RVT,c Gina Blecker,c and Timothy R. S. Harward, MD,a Orange and Irvine, Calif
Objectives: The purpose of vascular disease screening is early identification of atherosclerotic disease and the aim of an
ankle-brachial index (ABI) is to identify lower extremity (LE) atherosclerosis as a marker for coronary artery disease
(CAD). However, early evidence of atherosclerosis may be present in the superficial femoral artery (SFA) with a normal
resting ABI. This study was performed to determine if SFA duplex ultrasound (DUS) could detect more patients with LE
atherosclerosis than an ABI; be performed in the same or less time as the ABImeasurement; and be associated with similar
vascular disease markers as the ABI.
Methods: From January throughNovember 2006, 585 patients were screened for peripheral arterial disease. SFADUSwas
included in this Institutional Review Board approved program and demographic/ultrasound data were collected
prospectively. SFA DUS findings were divided into six categories. Plaque w/o color change or worse and ABI <0.90 or
>1.20 were considered to be abnormal. Data were evaluated using decision matrix and logistical regression analysis.
Results: Sensitivity and specificity of SFA DUS using the ABI as the benchmark was 100% and 88%, respectively.
Sensitivity and specificity of ABI was 17% and 100%, respectively, using DUS as the standard. DUS detected atheroscle-
rotic disease in 143 SFAs (93 patients) in which the ipsilateral ABI was normal, and there were no false negative SFADUS
studies. Multivariate logistic regression analysis demonstrated the following variables to be significantly and indepen-
dently associated with an abnormal SFA DUS as well as an abnormal ABI: history of claudication, history of myocardial
infarction, and an abnormal carotid DUS. Additional variables (current or past smoker and age >55) were also
independently associated with an abnormal SFA DUS but not with an abnormal ABI. Mean time to complete bilateral
testing was essentially the same for both tests.
Conclusions: SFADUS is an accurate screening tool and can be utilized in screening protocols in place of the time-honored
ABI without prolonging the examination. Traditional vascular disease markers that are found in patients with an
abnormal ABI are also associated with an abnormal SFA DUS. SFA DUS identifies more patients with early LE
atherosclerosis than does ABI without missing significant popliteal/tibial artery occlusive disease. Finally, an abnormal
SFA DUS can be used as an indirect marker to identify more potentially at risk patients with CAD. (J Vasc Surg 2008;
47:789-93.)The purpose of vascular disease screening is to identify
early evidence of atherosclerotic disease. The rationale for
carotid and abdominal aortic ultrasound imaging is to
prevent stroke and aneurysm rupture respectively while the
aim of an ankle-brachial index (ABI) is to identify lower
extremity atherosclerosis as a marker for coronary artery
disease (CAD).1-6 However, significant atherosclerosis may
be present in the superficial femoral artery (SFA) in limbs
with a normal resting ABI. Therefore, utilization of duplex
ultrasound (DUS) for the lower extremity component of
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doi:10.1016/j.jvs.2007.11.023peripheral vascular screening may provide for earlier iden-
tification of at risk patients with early atherosclerosis and
occult CAD than does the ABI. This study was performed
to determine if SFA DUS could (1) detect more patients
with lower extremity atherosclerosis than an ABI without
missing significant popliteal/tibial artery disease, (2) be
performed in the same or less time as the ABI measure-
ment, and (3) be associated with similar vascular disease
markers as the ABI.
METHODS
From January 2006 through November 2006, 585
patients were screened for peripheral arterial disease at the
St Joseph Hospital Vascular Institute (Orange, Calif) in-
cluding 341 (58%) women and 244 (42%) men. The non-
invasive vascular laboratory is Intersocietal Commission for
theAccreditation ofVascular Laboratories (ICAVL)-certified,
and this study as well as the screening program received
Institutional Review Board approval. The program in-
cluded a quick carotid ultrasound study to detect plaque
and to estimate degree of stenosis based on high resolution
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detect aortic dilation, and measurement of bilateral ABIs to
detect lower extremity ischemia.1 DUS of the SFAs was
added to the screening program for the duration of the
study and demographic as well as ultrasound data were
collected in a prospective fashion.
The studies were initially interpreted by an ultrasound
technician with oversight from three noninvasive labora-
tory experienced vascular surgeons. Estimated degree of
carotid stenosis was stratified into normal (15%), mild
(15% to 40%), moderate (40% to 60%), and severe (60%)
based on B-mode imaging of identified plaque. The ab-
dominal ultrasound was considered to be abnormal when
the infrarenal aortic diameter was 3 cm. The ABI was
considered to be abnormal if it was 0.90 or 1.20. SFA
DUS findings were divided into six categories: normal,
intimal thickening 2 mm, plaque w/o color change (in-
tima thickness2-3 mm with acoustic shadowing), plaque
w/color change and 50% stenosis (peak systolic velocity
[PSV] ratio2, plaque w/color change and50% stenosis
(PSV ratio 2), and occlusion.
All DUS studies were performed with a Siemens (New
York, NY) Antares ultrasound unit using the arterial pre-set
function. Duplex angles selected were 60 degrees, and a
VF 9-4 linear array probe was used in all cases. The specific
protocol regarding superficial femoral artery scanning was
as follows: the patient was covered with a sheet and then
lower extremity clothing was positioned to below knee
level. The right thigh was exposed and longitudinal scan-
ning was performed with color. The common femoral and
superficial femoral arteries were observed for any plaque
and/or color change. Peak systolic velocities were obtained
at any color change area. In addition, peak systolic veloci-
ties were obtained immediately proximal to the color
change area so that a velocity ratio could be calculated. The
above mentioned steps were repeated for the left thigh.
For the purposes of decision matrix analysis, an abnor-
mal carotid ultrasound result was defined as mild stenosis or
worse. SFA DUS that showed plaque w/o color change or
worse and ABI0.90 or1.20 were also considered to be
abnormal. SPSS software (SPSS Inc, Chicago, Ill) was used
to perform all statistical investigations, and this included
decision matrix analysis and univariate as well as multivari-
ate logistical regression analysis. A P value .05 was con-
sidered to be statistically significant.
RESULTS
Table I demonstrates pertinent patient demographic
data. The sensitivity and specificity of SFA DUS using the
ABI as the benchmark was 100% (95% confidence interval
[CI]; 0.854-1.00) and 88% (95%CI; 0.854-0.893), respec-
tively. Sensitivity and specificity of the ABI was 17% (95%
CI; 0.117-0.235) and 100% (95% CI; 0.995-1.00), respec-
tively, using SFA DUS as the standard. DUS detected
evidence of early atherosclerotic disease in 143 SFAs (93
patients; 16% of total patients) in which the ipsilateral ABI
was normal, and there were no false negative SFA DUS
studies. Among the abnormal SFADUS examinations (cat-egory 2), 78 (85%) were bilateral and 15 (15%) were
unilateral. Early atherosclerotic disease was evident in the
very proximal SFA in the majority of patients (75%).
Forty patients (7%) had risk factors for atherosclerosis
and an abnormal SFA DUS examination but had normal
ABIs and no history of clinically evident atherosclerotic
events such as myocardial infarction (MI), claudication,
stroke, or electrocardiogram (EKG) changes. An addi-
tional 38 patients (6.5%) with normal SFA DUS and
ABIs had risk factors for atherosclerosis but no history of
clinically evident atherosclerotic events (eg, MI, claudi-
cation, stroke, EKG changes).
Univariate analysis demonstrated the following vari-
ables to be associated with an abnormal SFA DUS: age
55 (P  .001), current or past smoker (P  .001),
diabetes (P  .001), claudication (P  .001), abnormal
EKG (P  .014), history of MI (P  .001), history of
stroke (P  .005), and abnormal carotid DUS (P 
.001). Backward stepwise logistic regression analysis dem-
onstrated the following variables to be independently asso-
ciated with an abnormal SFA DUS: age 55, current or
past smoker, history of claudication, history of MI, and
abnormal carotid DUS (Table II). Univariate analysis dem-
onstrated fewer variables to be associated with an abnormal
ABI, and these were: age 55 (P  .001), current or past
smoker (P .006), diabetes (P  .013), history of claudi-
cation (P  .001), history of MI (P  .005), and an
abnormal carotid DUS (P  .001). Backward stepwise
logistic regression analysis demonstrated that history of
claudication, history of MI, and an abnormal carotid DUS
were significantly and independently associated with an
abnormal ABI (Table II). Mean time to complete bilateral
testing was essentially the same for both tests (DUS 4.49
minutes; ABI  4.68 minutes, respectively; P  NSS).
DISCUSSION
Vascular screening programs facilitate early identifica-
Table I. Patient demographics
Yes # (%) No # (%)
Current smoker 46 (8.0) 539 (92)
Past smoker 263 (45) 322 (55)
Elevated cholesterol 301 (52) 284 (48)
Taking cholesterol meds 196 (34) 389 (66)
Hypertension 255 (44) 330 (56)
Taking HTN meds 225 (39) 360 (61)
Diabetes 59 (10) 526 (90)
Taking DM meds (oral/insulin) 56 (9) 529 (91)
Claudication symptoms 50 (8) 535 (92)
CAD or angina (current/past) 100 (17) 485 (83)
Taking angina/CAD meds 29 (5) 556 (95)
Abnormal EKG 97 (17) 488 (83)
History of MI 21 (4) 564 (96)
History of stroke 23 (4) 562 (96)
Age (mean 62, range 26 to 92)
CAD, Coronary artery disease; EKG, electrocardiogram; MI, myocardial
infarction.tion of atherosclerotic disease in readily accessible vascular
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disease in other vascular regions.1,2 Peripheral arterial dis-
ease of the lower extremities (PAD) is a common manifes-
tation of this atherosclerotic process. However, among the
usual arterial sites for atherosclerosis, PAD is probably the
most under-diagnosed and least aggressively managed.2-4
Patients with PAD are at increased risk for all-cause mor-
tality, and the ABI is well established as an independent
predictor of cardiovascular morbidity and mortality.2-6 In
screening programs, the rationale for obtaining carotid and
abdominal aortic duplex ultrasound imaging is to prevent
stroke and aneurysm rupture, respectively, while the aim of
an ABI is to identify lower extremity (LE) atherosclerosis as
a marker for CAD.2-6
The time-honored ABI correlates well with angio-
graphic disease severity as well as functional symptoms.2
However, noncompressible tibial vessels and hemodynam-
ically significant disease within the subclavian/axillary ar-
teries are limitations of the test’s ability to establish the
diagnosis of PAD.2This is particularly true in diabetic patients
where arterial medial calcinosis may artificially elevate the ABI
to normal levels. In a screening program, this could lead to the
false impression of normalcy despite evidence of early athero-
sclerosis that could be diagnosed using a more sensitive non-
invasive screening tool. Duplex ultrasound, which is equally as
noninvasive as theABI, is not limited as a screening tool by the
nature of the arterial disease process.
This prospective study demonstrated that SFA DUS is
more sensitive and specific than the ABI for early detection
of atherosclerosis in the lower extremities. Since lower
extremity atherosclerosis is a known marker for CAD, SFA
DUS therefore can identify more potentially at risk patients
with occult CAD than does the ABI. This finding has
important implications as all patients with early manifesta-
tions of PAD should receive treatment to maintain or
improve function, to reduce or eliminate ischemic symp-
toms, and to prevent disease progression in all vascular beds
including coronary.2-4 Patient education and modification
of risk factors such as smoking, hypertension, dyslipidemia,
and diabetes is crucial in this regard.2-6 In addition, there
Table II. Results of backward stepwise multivariate
regression analysis
P value OR 95% CI
Abnormal SFA DUS
Age 55 .001 4.91 2.4-10.03
Current/past smoker .047 1.73 1.01-2.97
History of claudication .004 2.97 1.42-6.23
History of MI .001 6.99 2.4-20.01
Abnormal carotid DUS .001 4.72 2.69-8.29
Abnormal ABI
History of claudication .042 2.97 1.04-8.48
History of MI .031 4.43 1.15-17.1
Abnormal carotid DUS .002 11.63 2.56-52.9
OR, Odds ratio, SFA, superficial femoral artery; DUS, duplex ultrasound;
MI, myocardial infarction; ABI, ankle-brachial index.were no false negative SFA DUS studies, which indirectlymeans that the study can be confidently performed without
fear of missing significant popliteal/tibial artery occlusive
disease.
This study additionally demonstrated that traditional
vascular disease markers such as claudication, CAD, and
cerebrovascular occlusive disease were associated with both
an abnormal ABI as well as an abnormal SFA DUS. Ciga-
rette smoking and age 55 were also significantly and
independently associated with an abnormal SFA DUS even
when the ABI was normal. In fact, more vascular disease
specific demographic variables were associated with an ab-
normal SFA DUS then an abnormal ABI using both uni-
variate and multivariate logistic regression analysis. Inter-
estingly, eight patients (1.4% of patient total) had an
abnormal SFA DUS with no risk factors and normal ABIs.
Although this percentage is quite small and we do not have
long-term follow-up data regarding subsequent cardiac
events in this patient cohort, a large prospective study could
possibly demonstrate that finding and treating atheroscle-
rosis earlier and globally might positively affect its natural
history. Furthermore, 1.4% could translate into a very large
number of patients when screening is applied on a grand
scale.
The benefit of using SFA DUS for vascular screening
becomes more compelling when considering that 7% of
patients who participated in this nonselective screening
program had risk factors for atherosclerosis and an abnor-
mal SFA DUS examination yet had normal ABIs and no
history of clinically evident atherosclerotic events such as
MI, claudication, stroke, or EKG changes. Such patients
should benefit significantly from a screening program as
they likely would receive more intense risk factor manage-
ment as well as education about vascular disease.6 Addi-
tionally, the 6.5% of patients in our study who had normal
SFA DUS and ABIs but had risk factors for atherosclerosis
without a history of clinically evident atherosclerotic
events, might also well benefit from increased intensity in
the management and treatment of risk factors before clini-
cal events occur.
Finally, since the mean time to complete bilateral test-
ing was essentially the same for both tests, another positive
aspect of the utilization of SFA DUS for vascular screening
programs is that ABI equipment is not necessary and the
variability in obtaining an accurate ABI measurement from
patient to patient is also eliminated. There are also potential
sources of variability with SFA DUS; however, these can be
minimized by using well-trained technologists and by
quantifying intima thickness measurements and PSV ratios
as described in the protocol.
CONCLUSIONS
SFA DUS is an accurate screening tool and can be
utilized in screening protocols in place of the time-honored
ABI without prolonging the examination. Traditional vas-
cular disease markers that are found in patients with an
abnormal ABI are also associated with an abnormal SFA
DUS. SFA DUS identifies more patients with early LE
atherosclerosis than does ABI without missing significant
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mal SFA DUS can be used as an indirect marker to identify
more potentially at risk patients with CAD.
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Dr Zierler (Seattle, Wash). There has been a resurgence of
interest in vascular disease screening in recent years, particularly in
the areas of carotid disease, abdominal aortic aneurysms, and
peripheral arterial disease. As a past-president of the Intersocietal
Commission for the Accreditation of Vascular Laboratories, I
would encourage you to review the new standards for screening
that the ICAVL has developed, particularly if you already have an
accredited lab. With regard to the study that you just heard about,
I recognize that there is controversy over the merits of PAD
screening with respect to selection of patients, how the results
should be used, whether there is really any long-term benefit, and
so on, but I will focus my remarks today on the testing methods
used, because I think that is really where a lot of the interest lies.
Because of its simplicity and general availability, the ABI has
been the standard for PAD screening up to this point. However,
this paper introduces an alternative screening approach to PAD
based on duplex ultrasound of the superficial femoral artery, and it
describes a prospective study comparing it to the standard ABI.
The authors concluded that duplex ultrasoundwas amore sensitive
test than ABI and therefore was a better screening method for
PAD.
From my point of view, it is reassuring to have this shown in a
well-done prospective clinical study, but it is really not surprising at
all. After all, the ABI is an indirect test that assesses the distal effects
of arterial disease and allows us to make inferences about how
severe the lesions might be. It does not really allow us to detect the
early or minimal stages of atherosclerosis because a relatively large
burden of atherosclerosis is required to create a pressure gradient in
the leg and produce a positive test. So the ABI really should not be
a very good screening test for PAD, yet that is what we use. Duplex
scanning is a direct test that looks “directly” at the lesions of
interest. Therefore, it has the potential for detection of early or
minimal disease. This is analogous to the old OPG [oculoplethys-
mography] test vs duplex scanning for carotid disease, for those of
you who remember that test.
Since interpretation of the duplex ultrasound exams is a key
component of this study, I would like to raise some issues regard-
ing that aspect before I pose some specific questions. The manu-
script, and I think the presentation as well, described six categories
of ultrasound findings related to the SFA and these were based on
features such as intimal thickening, plaque, color changes, and so
on. For the purposes of this study, intimal thickening was a
negative test, but plaque without color change and less than 50%
stenosis were positive tests. The measurement of intimal-medial
thickness, or IMT, in the carotid artery has been established as a
tool for assessing cardiovascular risk and I see some parallels
between what was described in this study for the SFA and IMT inis a little bit vague. It is not quantitative the way IMT is, so I
wonder about the variability and reproducibility of some of the
results.
I have four questions. I usually advise discussants to limit
themselves to three questions, but I am going to ask four questions
because they are relatively brief. Number 1, color flow imaging is
subject to the same errors and artifacts as Doppler spectral analysis.
What can you tell us about standardization of your ultrasound
protocol with regard to instrument setup, color scale, Doppler
angle, and transducer selection—all the things that affect the way
the color flow image looks and therefore could affect your inter-
pretation?
Number 2, when does intimal thickening become plaque
without color change? This is not clear and obviously affects the
interpretation. With IMT you actually get a number, but your
interpretation appears to be more subjective than that.
Number 3, the variability of ABI measurements is well known.
I must have quoted Dr Dennis Baker’s old paper on this hundreds
of times in my career, but do you have any data on your variability
of duplex ultrasound interpretation? I realize that you do not have
a huge series, but maybe you have some impressions that you could
offer.
And, number 4, it appears that you examined the entire SFA
on both sides of these patients. It is well known that the earliest site
for atherosclerosis in the leg is the adductor canal segment of the
SFA. Can you tell us anything about the distribution of disease
along the SFA? Was it distal, was it mid, or was it proximal? Would
it be possible to limit a screening test to the distal SFA on one side
or the other side? Is there some way you could streamline this
exam? That would be interesting to know.
As a final thought, I think that duplex ultrasound should be a
better screening test for PAD than ABI, but I think the ABI still has
some advantages, particularly in the office setting, because it re-
quires suchminimal equipment, time, and effort. I compliment the
authors on this very interesting study and I appreciate the oppor-
tunity to discuss it.
Dr Ballard. Gene asked about the specifics of the ultrasound
study. We have Siemens Anteres ultrasound machines, which have
an arterial preset that we select to scan the vessels. Doppler angle is
always set to less than 60 degrees. The transducer is a VF94 linear
array and we use the same protocol for every patient. The two
technicians who were involved in this study are very experienced,
thus the protocol was well standardized.
When does intimal thickening become plaque? That is a very
good question, and in retrospect, it would have been instructive to
have quantified intimal thickening exactly by measuring IMT.
However, in this study, intimal thickening was diagnosed when the
usual thin white line of intima was raised more than 2 mm and
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thickened areas. The reason that we did not select just intimal
thickening as an abnormal test result was because that criterion
alone makes ultrasound too sensitive to be useful as a screening
tool.
The variability of the ankle-brachial index is well known. I do
not have specific data on the variability of the ultrasound test but in
this particular study protocol, two experienced technicians per-
formed the examinations over and over again, which limited po-
tential variability.
Finally, you asked if we could shorten or limit the exam because
of the fact that superficial femoral artery disease begins at the adductorhiatus. We assume this because SFA atherosclerotic disease appears in
this area per angiography that is performedwhen the patient becomes
symptomatic or has a significant drop in the ABI. Interestingly,
screening ultrasound detected more disease in the proximal aspect of
the superficial femoral artery just beyond the terminal common fem-
oral artery. So in fact, the adductor hiatus may not be the first place
that SFA disease starts. Based on our ultrasound findings, one could
potentially limit the study to the proximal half of the SFA if there was
a pressing need to shorten the exam.
